BLAC EV/EBITDA
-21.24
0.000.00%
Fri, 31 Jan 2025 14:30:00 GMT
Summary:
As of February 3, 2025, BLAC EV/EBITDA is -21.24, unchanged from the previous trading day. Over the past year, it has increased by +11.29 (+34.71%). BLAC EV/EBITDA is now -4.68% below its all-time high of -20.29.BLAC EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BLAC EV/EBITDA Performance
| PeriodPeriod | EV/EBITDAEV/EBITDA |
|---|---|
| todaytoday | 0.0% |
| 1 m1 month | +1.5% |
| 3 m3 months | -2.6% |
| 6 m6 months | -3.5% |
| ytdytd | +1.5% |
| 1 y1 year | +34.7% |
| 5 y5 years | - |
BLAC EV/EBITDA High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -21.17 | -0.3% | -22.28 | +4.7% |
| 3 m | 3-month | -20.63 | -3.0% | -22.87 | +7.1% |
| 6 m | 6-month | -20.29 | -4.7% | -22.87 | +7.1% |
| 1 y | 1-year | -20.29 | -4.7% | -32.67 | +35.0% |
| 3 y | 3-year | -20.29 | -4.7% | -294.17 | +92.8% |
| 5 y | 5-year | -20.29 | -4.7% | -294.17 | +92.8% |
| alltime | all time | -20.29 | -4.7% | -294.17 | +92.8% |
Bellevue Life Sciences Acquisition EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -21.24(-1.5%) |
| Date | Value |
|---|---|
| 2024 | -21.57(-33.1%) |
| 2023 | -32.24 |
FAQ
- What is Bellevue Life Sciences Acquisition EV/EBITDA?
- What is the all time high EV/EBITDA for Bellevue Life Sciences Acquisition?
- What is BLAC EV/EBITDA year-to-date change?
- What is Bellevue Life Sciences Acquisition EV/EBITDA year-on-year change?
What is Bellevue Life Sciences Acquisition EV/EBITDA?
The current EV/EBITDA of BLAC is -21.24
What is the all time high EV/EBITDA for Bellevue Life Sciences Acquisition?
Bellevue Life Sciences Acquisition all-time high EV/EBITDA is -20.29
What is BLAC EV/EBITDA year-to-date change?
Bellevue Life Sciences Acquisition EV/EBITDA has changed by +0.33 (+1.53%) since the beginning of the year
What is Bellevue Life Sciences Acquisition EV/EBITDA year-on-year change?
Over the past year, BLAC EV/EBITDA has changed by +11.29 (+34.71%)